Avacta Group (LON:AVCT) Trading Up 12.7% - What's Next?

Avacta Group Plc (LON:AVCT - Get Free Report) was up 12.7% during mid-day trading on Tuesday . The company traded as high as GBX 31 ($0.42) and last traded at GBX 31 ($0.42). Approximately 3,044,731 shares were traded during mid-day trading, an increase of 80% from the average daily volume of 1,689,436 shares. The stock had previously closed at GBX 27.50 ($0.37).

Avacta Group Stock Performance

The firm has a 50 day moving average of GBX 34.82 and a 200-day moving average of GBX 42.17. The company has a market cap of £117.77 million, a P/E ratio of -3.99 and a beta of 1.12. The company has a quick ratio of 4.96, a current ratio of 1.29 and a debt-to-equity ratio of 52.53.

About Avacta Group

Avacta Therapeutics is a clinical stage biopharmaceutical company challenging current drug delivery methods to expand the utility of highly potent cancer therapeutics. The Company benefits from a world class research and development facility, team of exceptionally talented scientists and a highly experienced management team with members located in both the London headquarters and the US. Our proprietary pre|CISION® platform masks toxic warheads by binding them to a short, engineered peptide that is cleavable only by the tumor-specific protease, fibroblast activation protein (FAP).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.